Plecanatide and its Impurities

Plecanatide is a drug approved in January 2017 by the FDA for the treatment of chronic idiopathic constipation (CIC). It should not be used in children less than six years of age, and should be avoided in patients six years to 18 years of age Reference standards of Plecanatide API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.